• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy.

作者信息

Talja M, Tammela T, Petas A, Välimaa T, Taari K, Viherkoski E, Törmälä P

机构信息

Department of Surgery, Päijät-Häme Central Hospital, Lahti.

出版信息

J Urol. 1995 Dec;154(6):2089-92.

PMID:7500465
Abstract

PURPOSE

The efficacy and safety of a new biodegradable (self-reinforced polyglycolic acid) spiral stent in securing free voiding despite edema after visual laser ablation of the prostate were studied.

MATERIALS AND METHODS

A biodegradable spiral stent was inserted into the prostatic urethra in 22 patients immediately after visual laser ablation of the prostate. Uroflowmetry, measurement of residual urine volume, urine culture, cystoscopy and assessment of symptomatic improvement were done before, and 1, 3 and 6 months after visual laser ablation of the prostate.

RESULTS

All 22 patients voided freely on day 1 or 2 after visual laser ablation of the prostate. However, 4 patients later had urinary retention due to a short spiral or too rapid spiral degradation. Half of the patients experienced a transient decrease in flow with some obstructive symptoms at 3 weeks that lasted 1 to 2 weeks. At 4 weeks all spirals were degraded and 3 patients had a positive urine culture. The maximum flow rate increased and the residual urine volume decreased significantly concomitantly with significant symptomatic improvement.

CONCLUSIONS

The self-reinforced polyglycolic acid spiral stent can effectively and safely prevent postoperative urinary retention after visual laser ablation of the prostate.

摘要

相似文献

1
Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy.
J Urol. 1995 Dec;154(6):2089-92.
2
A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.
J Urol. 1997 Jan;157(1):173-6.
3
Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.
J Urol. 2001 Sep;166(3):919-22.
4
Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.可生物降解编织聚乳酸-乙醇酸共聚物尿道支架联合度他雄胺治疗良性前列腺增生所致急性尿潴留:一项初步研究。
BJU Int. 2009 Mar;103(5):626-9. doi: 10.1111/j.1464-410X.2008.08111.x. Epub 2008 Oct 16.
5
Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.
J Endourol. 2002 Jun;16(5):311-5. doi: 10.1089/089277902760102811.
6
The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.
Br J Urol. 1997 Sep;80(3):439-43. doi: 10.1046/j.1464-410x.1997.00308.x.
7
The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.经尿道前列腺切除术及4种微创治疗替代方案的术后早期发病率。
J Urol. 1997 Jul;158(1):105-10; discussion 110-1. doi: 10.1097/00005392-199707000-00029.
8
A randomised study to evaluate the efficacy of a biodegradable stent in the prevention of postoperative urinary retention after interstitial laser coagulation of the prostate.一项评估可生物降解支架预防前列腺间质激光凝固术后尿潴留疗效的随机研究。
Scand J Urol Nephrol. 2000 Aug;34(4):262-6. doi: 10.1080/003655900750042004.
9
Intermittent catheterization time required after interstitial laser coagulation of the prostate.前列腺间质激光凝固术后所需的间歇性导尿时间。
Urology. 2004 Jul;64(1):79-83. doi: 10.1016/j.urology.2004.03.009.
10
Laser prostatectomy with a TURPETTE: evolution with right-angle technique.使用TURPETTE的激光前列腺切除术:直角技术的进展
Tech Urol. 1995 Spring;1(1):11-8.

引用本文的文献

1
Comparison of a poly-L-lactide-co-ε-caprolactone and human amniotic membrane for urothelium tissue engineering applications.聚-L-乳酸-共-ε-己内酯与人类羊膜在尿路上皮组织工程应用中的比较。
J R Soc Interface. 2011 May 6;8(58):671-7. doi: 10.1098/rsif.2010.0520. Epub 2010 Nov 24.
2
Tissue biocompatibility of new biodegradable drug-eluting stent materials.新型可生物降解药物洗脱支架材料的组织生物相容性
J Mater Sci Mater Med. 2007 Aug;18(8):1543-7. doi: 10.1007/s10856-007-3060-3. Epub 2007 Apr 17.
3
[Bioartificial materials in urology].
Urologe A. 2004 Oct;43(10):1200-7. doi: 10.1007/s00120-004-0688-1.
4
Urethral stents in benign prostate hyperplasia.
Curr Urol Rep. 2003 Aug;4(4):282-6. doi: 10.1007/s11934-003-0085-0.
5
Benign prostatic hyperplasia. Practical treatment guidelines.良性前列腺增生。实用治疗指南。
Drugs Aging. 1997 May;10(5):349-66. doi: 10.2165/00002512-199710050-00004.